Increased serum total antioxidant status and decreased urinary 8-hydroxy-2′-deoxyguanosine levels in patients with normal-tension glaucoma

Acta Ophthalmologica

Volumn 88, Issue 7, 2010, Pages

  Yuki, Kenya ^a   Murat, Dogru ^a   Kimura, Itaru ^a   Tsubota, Kazuo ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

8 hydroxy 2 deoxyguanosine; normal tension glaucoma; oxidative stress; serum total antioxidant status

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ANTIOXIDANT; CHOLESTEROL; CREATININE; FRUCTOSAMINE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD LEVEL; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE URINE LEVEL; DIASTOLIC BLOOD PRESSURE; DNA DAMAGE; FEMALE; FRUCTOSAMINE BLOOD LEVEL; GLAUCOMA; HUMAN; HYPERTENSION; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; NORMAL TENSION GLAUCOMA; OXIDATIVE STRESS; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URINE LEVEL;

AGED; ANTIOXIDANTS; COLORIMETRY; CREATININE; DEOXYGUANOSINE; DNA DAMAGE; FEMALE; HUMANS; INCIDENCE; LOW TENSION GLAUCOMA; MALE; MIDDLE AGED; OXIDATIVE STRESS;

EID: 78349260481     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2010.01997.x     Document Type: Article

References (52)

1. Barassi A, Colpi GM, Piediferro G, Dogliott G, Melzi D'Eril GV, &, Corsi MM, (2009): Oxidative stress and antioxidant status in patients with erectile dysfunction. J Sex Med 6: 2820 - 2825.
2. Becker BF, (1993): Towards the physiological function of uric acid. Free Radic Biol Med 14: 615 - 631.
3. Chen J, He J, Hamm L, Batuman V, &, Whelton PK, (2002): Serum antioxidant vitamins and blood pressure in the United States population. Hypertension 40: 810 - 816. (Pubitemid 35434899)
4. Coleman AL, &, Miglior S, (2008): Risk factors for glaucoma onset and progression. Surv Ophthalmol 53 (Suppl. 1): S3 - S10.
5. Coleman AL, Stone KL, Kodjebacheva G, et al. (2008): Glaucoma risk and the consumption of fruits and vegetables among older women in the study of osteoporotic fractures. Am J Ophthalmol 145: 1081 - 1089.
6. Collaborative Normal-Tension Glaucoma Study Group (1998): The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol 126: 498 - 505.
7. Cutler RG, (1984): Urate and ascorbate: their possible roles as antioxidants in determining longevity of mammalian species. Arch Gerontol Geriatr 3: 321 - 348.
8. Deokule S, &, Weinreb RN, (2008): Relationships among systemic blood pressure, intraocular pressure, and open-angle glaucoma. Can J Ophthalmol 43: 302 - 307.
9. Emeriau JP, Decamps A, Manciet G, Dupuy-Braud E, &, Galley P, (1988): Hypertension in the elderly. Am J Med 84: 92 - 97.
10. Evelson P, Travacio M, Repetto M, Escobar J, Llesuy S, &, Lissi EA, (2001): Evaluation of total reactive antioxidant potential (TRAP) of tissue homogenates and their cytosols. Arch Biochem Biophys 388: 261 - 266.
11. Ferreira SM, Lerner SF, Brunzini R, Evelson PA, &, Llesuy SF, (2004): Oxidative stress markers in aqueous humor of glaucoma patients. Am J Ophthalmol 137: 62 - 69.
12. Fischer MA, Gransier TJ, Beckers LM, Bekers O, Bast A, &, Haenen GR, (2005): Determination of the antioxidant capacity in blood. Clin Chem Lab Med 43: 735 - 740.
13. Foster A, &, Resnikoff S, (2005): The impact of Vision 2020 on global blindness. Eye 19: 1133 - 1135.
14. Gherghel D, Griffiths HR, Hilton EJ, Cunliffe IA, &, Hosking SL, (2005): Systemic reduction in glutathione levels occurs in patients with primary open-angle glaucoma. Invest Ophthalmol Vis Sci 46: 877 - 883.
15. Glantzounis GK, Tsimoyiannis EC, Kappas AM, &, Galaris DA, (2005): Uric acid and oxidative stress. Curr Pharm Des 11: 4145 - 4151.
16. Gordon MO, Beiser JA, Brandt JD, et al. (2002): The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 120: 714 - 720. discussion 829-30.
17. Harada T, Harada C, Nakamura K, et al. (2007): The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma. J Clin Invest 117: 1763 - 1770.
18. Horwath-Winter J, Kirchengast S, Meinitzer A, Wachswender C, Faschinger C, &, Schmut O, (2009): Determination of uric acid concentrations in human tear fluid, aqueous humour and serum. Acta Ophthalmol 87: 188 - 192.
19. Iwase A, Suzuki Y, Araie M, et al. (2004): The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. Ophthalmology 111: 1641 - 1648.
20. Iwase A, Araie M, Tomidokoro A, Yamamoto T, Shimizu H, &, Kitazawa Y, (2006): Prevalence and causes of low vision and blindness in a Japanese adult population: the Tajimi Study. Ophthalmology 113: 1354 - 1362.
21. Kang JH, Pasquale LR, Willett W, Rosner B, Egan KM, Faberowski N, &, Hankinson SE, (2003): Antioxidant intake and primary open-angle glaucoma: a prospective study. Am J Epidemiol 158: 337 - 346. (Pubitemid 41288801)
22. Kang JH, Pasquale LR, Willett WC, Rosner BA, Egan KM, Faberowski N, &, Hankinson HE, (2004): Dietary fat consumption and primary open-angle glaucoma. Am J Clin Nutr 79: 755 - 764.
23. Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, &, Komaroff E, (2003): Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol 121: 48 - 56. (Pubitemid 36401765)
24. Leske MC, Heijl A, Hyman L, Bengtsson B, Dong L, &, Yang Z, (2007): Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology 114: 1965 - 1972.
25. Leske MC, Wu SY, Hennis A, Honkanen R, &, Nemesure B, (2008): Risk factors for incident open-angle glaucoma: the Barbados Eye Studies. Ophthalmology 115: 85 - 93. (Pubitemid 350309410)
26. Loft S, &, Poulsen HE, (1998): Estimation of oxidative DNA damage in man from urinary excretion of repair products. Acta Biochim Pol 45: 133 - 144.
27. Loft S, Fischer-Nielsen A, Jeding IB, Vistisen K, &, Poulsen HE, (1993): 8-Hydroxydeoxyguanosine as a urinary biomarker of oxidative DNA damage. J Toxicol Environ Health 40: 391 - 404.
28. Maxwell SR, Thomason H, Sandler D, Leguen C, Baxter MA, Thorpe GH, Jones AF, &, Barnett AH, (1997): Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus. Eur J Clin Invest 27: 484 - 490.
29. Mitch WE, Johnson MW, Kirshenbaum JM, &, Lopez RE, (1981): Effect of large oral doses of ascorbic acid on uric acid excretion by normal subjects. Clin Pharmacol Ther 29: 318 - 321.
30. Munemasa Y, Kim SH, Ahn JH, Kwong JM, Caprioli J, &, Piri N, (2008): Protective effect of thioredoxins 1 and 2 in retinal ganglion cells after optic nerve transection and oxidative stress. Invest Ophthalmol Vis Sci 49: 3535 - 3543.
31. Muskens RP, De Voogd S, Wolfs RC, Witteman JC, Hofman A, De Jong PT, Stricker BH, &, Jansonius NM, (2007): Systemic antihypertensive medication and incident open-angle glaucoma. Ophthalmology 114: 2221 - 2226.
32. Nakajima Y, Inokuchi Y, Nishi M, Shimazawa M, Otsubo K, &, Hara H, (2008): Coenzyme Q10 protects retinal cells against oxidative stress in vitro and in vivo. Brain Res 1226: 226 - 233.
33. Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, &, Rice-Evans C, (1999): Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med 26: 1231 - 1237.
34. Ren H, Magulike N, Ghebremeskel K, &, Crawford M, (2006): Primary open-angle glaucoma patients have reduced levels of blood docosahexaenoic and eicosapentaenoic acids. Prostaglandins Leukot Essent Fatty Acids 74: 157 - 163.
35. Romay C, Pascual C, &, Lissi EA, (1996): The reaction between ABTS radical cation and antioxidants and its use to evaluate the antioxidant status of serum samples. Braz J Med Biol Res 29: 175 - 183.
36. Sevanian A, Davies KJ, &, Hochstein P, (1991): Serum urate as an antioxidant for ascorbic acid. Am J Clin Nutr 54: 1129S - 1134S.
37. Shields MB, (2008): Normal-tension glaucoma: is it different from primary open-angle glaucoma? Curr Opin Ophthalmol 19: 85 - 88.
38. Shimazawa M, Nakajima Y, Mashima Y, &, Hara H, (2009): Docosahexaenoic acid (DHA) has neuroprotective effects against oxidative stress in retinal ganglion cells. Brain Res 1251: 269 - 275.
39. Sinha S, Singh SN, &, Ray US, (2009): Total antioxidant status at high altitude in lowlanders and native highlanders: role of uric acid. High Alt Med Biol 10: 269 - 274.
40. Stein HB, Hasan A, &, Fox IH, (1976): Ascorbic acid-induced uricosuria. A consequency of megavitamin therapy. Ann Intern Med 84: 385 - 388.
41. Strube M, Haenen GR, Van Den Berg H, &, Bast A, (1997): Pitfalls in a method for assessment of total antioxidant capacity. Free Radic Res 26: 515 - 521.
42. Suzuki S, Suzuki Y, Iwase A, &, Araie M, (2005): Corneal thickness in an ophthalmologically normal Japanese population. Ophthalmology 112: 1327 - 1336.
43. Touyz RM, (2003): Reactive oxygen species in vascular biology: role in arterial hypertension. Expert Rev Cardiovasc Ther 1: 91 - 106.
44. Valavanidis A, Vlachogianni T, &, Fiotakis C, (2009): 8-hydroxy-2′ -deoxyguanosine (8-OHdG): a critical biomarker of oxidative stress and carcinogenesis. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 27: 120 - 139.
45. Waring WS, Webb DJ, &, Maxwell SR, (2001): Systemic uric acid administration increases serum antioxidant capacity in healthy volunteers. J Cardiovasc Pharmacol 38: 365 - 371.
46. Wilson MR, &, Creighton MS, (2002): Normal tension glaucoma. Acta Ophthalmol Scand Suppl 236: 9 - 11.
47. Wu LL, Chiou CC, Chang PY, &, Wu JT, (2004): Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta 339: 1 - 9.
48. Yildirim O, Ates NA, Ercan B, Muslu N, Unlu A, Tamer L, Atik U, &, Kanik A, (2005): Role of oxidative stress enzymes in open-angle glaucoma. Eye 19: 580 - 583.
49. Yuki K, Kimura I, &, Tsubota K, (2010a): Serum free fatty acids levels not associated with normal tension glaucoma. Clin Ophthalmol 4: 91 - 94.
50. Yuki K, Murat D, Kimura I, Ohtake Y, &, Tsubota K, (2010b): Reduced-serum vitamin C and increased uric acid levels in normal-tension glaucoma. Graefes Arch Clin Exp Ophthalmol 248: 243 - 248.
51. Zanon-Moreno V, Marco-Ventura P, Lleo-Perez A, Pons-Vazquez S, Garcia-Medina JJ, Vinuesa-Silva I, Moreno-Nadal MA, &, Pinazo-Duran MD, (2008): Oxidative stress in primary open-angle glaucoma. J Glaucoma 17: 263 - 268.
52. Zanon-Moreno V, Garcia-Medina JJ, Gallego-Pinazo R, Vinuesa-Silva I, Moreno-Nadal MA, &, Pinazo-Duran MD, (2009): Antioxidant status modifications by topical administration of dorzolamide in primary open-angle glaucoma. Eur J Ophthalmol 19: 565 - 571.